共 468 条
[1]
Gutierrez M(2017)Genomic profiling of advanced non-small cell lung cancer in community settings: gaps and opportunities Clin Lung Cancer 18 651-659
[2]
Choi K(2019)Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients Clin Oncol 37 1305-1315
[3]
Lanman R(2019)Clinical implications of plasma-based genotyping with the delivery of personalized therapy in metastatic non-small cell lung cancer JAMA Oncol 5 173-180
[4]
Kurian A(2017)Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancer Onco Targets Ther 10 2539-2551
[5]
Ward K(2017)PARP inhibitors: the first synthetic lethal targeted therapy Science. 355 1152-1158
[6]
Howlander N(2017)Olaparib for metatatic breast cancer in patients with a germline BRCA mutation N Engl J Med 377 523-533
[7]
Aggarwal C(2018)Talazoparib in patients with advanced breast cancer and germline BRCA mutation N Engl J Med 279 753-763
[8]
Thompson C(2018)Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer N Engl J Med 379 2495-2505
[9]
Black T(2019)Maintenance olaparib for germline N Engl J Med 381 317-327
[10]
Hollis RL(2019)-mutated metastatic pancreatic cancer Cancer Disc 9 210-219